| 摘要: |
| 目的 探讨吸入花形乳糖(FL)装载聚乙二醇(PEG)修饰姜黄素(Cur)固体脂质纳米粒(SLN)吸入微粉对脂多糖(LPS)叠加香烟烟雾(CS)诱导的慢性阻塞性肺疾病(COPD)模型小鼠肺部炎症的治疗作用,并揭示其分子机制。方法 通过鼻腔滴注LPS叠加吸入CS诱导建立小鼠COPD模型,随机选用10只小鼠鼻腔内滴注生理盐水作为正常对照组;其余50只小鼠鼻腔内滴注LPS后随机分为模型组、布地奈德组(20 mg·kg-1)和PEG-Cur-FL高、低剂量组(40 mg·kg-1、20 mg·kg-1),第5周开始,将鼻腔内滴注LPS的所有小鼠进行烟熏,每日2次,每次1h,隔天休息,连续4个月,复制COPD模型。第17周开始,每天经气管向各组小鼠给予相应药物,每日1次,持续28 d。末次给药24 h后,采集各组小鼠支气管肺泡灌洗液(BALF)并对其中的白细胞进行分类计数;ELISA试剂盒检测小鼠BALF中IL-1β、IL-6浓度;苏木素-伊红(HE)染色、Masson染色检测气管和肺组织病理形态和肺组织胶原纤维沉积;免疫组织化学法检测肺组织中肿瘤坏死因子(TNF-α)、基质金属蛋白酶-2(MMP-2)的阳性表达;Western blotting法检测肺组织中血管紧张素转换酶2(ACE2)和IL-6的蛋白表达。结果 与正常对照组比较,LPS+CS诱导的COPD小鼠BALF中白细胞总数、中性粒细胞数、淋巴细胞数、单核细胞数、嗜酸性粒细胞数和嗜碱性粒细胞数均显著增加(P<0.01);BALF中IL-6、IL-1β炎性因子含量明显升高(P<0.05);肺内支气管见纤毛柱状上皮增生增厚,脱落,腔内见黏液蓄积,肺泡结构紊乱,炎症细胞浸润,组织水肿,肺泡隔及肺间质见大量胶原纤维;肺组织中TNF-α、MMP-2的阳性表达明显增强(P<0.05),肺组织中ACE2受体表达水平明显下调(P<0.05),IL-6蛋白表达水平明显上调(P<0.05)。肺吸入PEG-Cur-FL后,上述指标均有明显的改善。结论 PEG-Cur-FL减轻LPS+CS诱导的COPD小鼠肺部炎症反应,其机制可能是通过上调ACE2受体的表达水平,减少了炎症因子合成释放,抑制胶原合成沉积,进而有效延缓肺组织衰竭的发生。 |
| 关键词: 姜黄素 聚乙二醇修饰固体脂质纳米粒 慢性阻塞性肺疾病 炎症因子 血管紧张素转换酶2 |
| DOI:10.13506/j.cnki.jpr.2025.08.001 |
| 基金项目:国家自然科学基金项目(No.81903565);天津市自然科学基金项目(No.21JCYBJC01630、23JCYBJC00410);天津市卫生健康委中医中西医结合科研项目(No.2023102) |
|
出版日期:2025-08-25
|
|
| Effects of flower-shaped lactose loaded PEG-modified curcumin solid lipid nanoparticles on the expression of inflammatory factors and ACE2 in lung tissue of COPD mice |
| LI Xu,WANG Zi,HAO Di,LI Nan |
| (Tianjin Institute of Medical and Pharmaceutical Sciences, 79 Duolun Road, Heping District, Tianjin 300020, China) |
| Abstract: |
| Objective To investigate the therapeutic effect of inhaling flower-shaped lactose loaded with PEG modified curcumin solid lipid nanoparticles on pulmonary inflammation in mice with chronic obstructive pulmonary disease induced by lipopolysaccharide and cigarette smoke, and to reveal its molecular mechanism. Methods Mouse COPD model was established by nasal instillation of LPS and inhalation of CS, and 10 mice were randomly selected as normal control group. The remaining 50 mice were randomly divided into model group, budesonide group (20 mg·kg-1) and PEG-Cur-FL high-dose and low-dose groups (40 mg·kg-1, 20 mg·kg-1) after intranasal infusion of LPS. From the fifth week, all mice with intranasal infusion of LPS were smoked twice a day, with 1 hour rest every other day, and the COPD model was reproduced for 4 months. From the 17th week, mice in each group were given corresponding drugs through trachea once a day for 28 days. Twenty-four hours after the last administration, bronchoalveolar lavage fluid (BALF) was collected and the white blood cells were classified and counted. The concentrations of IL-1β and IL-6 in BALF of mice were detected by ELISA kit. HEmatoxylin-eosin (He) staining and Masson staining were used to detect the pathological morphology of trachea and lung tissue and the deposition of collagen fibers in lung tissue. Immunohistochemical method was used to detect the positive expression of tumor necrosis factor-α and matrix metalloproteinase -2(MMP-2) in lung tissue. Western blotting was used to detect the protein expressions of angiotensin converting enzyme 2(ACE2) and IL-6 in lung tissue. Results Compared with the normal control group, the total number of white blood cells, neutrophils, lymphocytes, monocytes, eosinophils and basophils in BALF of COPD mice induced by LPS+CS increased significantly (P<0.01). The contents of IL-6 and IL-1β inflammatory factors in BALF increased significantly (P<0.05). Ciliary columnar epithelium hyperplasia, thickening and shedding were found in the bronchi of lung, mucus accumulation, alveolar structure disorder, inflammatory cell infiltration, tissue edema, and a large number of collagen fibers were found in alveolar septum and interstitial lung. The positive expression of TNF-α and MMP-2 in lung tissue was significantly enhanced (P<0.05), the expression level of ACE2 receptor in lung tissue was significantly decreased (P<0.05), and the expression level of IL-6 protein was significantly increased (P<0.05). After pulmonary inhalation of PEG-Cur-FL, all the above indexes were obviously improved.Conclusion PEG-Cur-FL can alleviate the lung inflammatory reaction induced by LPS+CS in COPD mice, and its mechanism may be that it can reduce the synthesis and release of inflammatory factors and inhibit the synthesis and deposition of collagen by up-regulating the expression level of ACE2 receptor, thus effectively delaying the occurrence of lung tissue failure. |
| Key words: Curcumin PEG modified solid lipid nanoparticles Chronic obstructive pulmonary disease Inflammatory factor ACE2 |